Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials.
Ng KT, Van Paassen J, Langan C, Sarode DP, Arbous MS, Alston RP, Dekkers OM. Ng KT, et al. Among authors: van paassen j. Eur J Cardiothorac Surg. 2020 Apr 1;57(4):620-627. doi: 10.1093/ejcts/ezz325. Eur J Cardiothorac Surg. 2020. PMID: 31972000
Prophylactic corticosteroids for cardiopulmonary bypass in adults.
Dieleman JM, van Paassen J, van Dijk D, Arbous MS, Kalkman CJ, Vandenbroucke JP, van der Heijden GJ, Dekkers OM. Dieleman JM, et al. Among authors: van der heijden gj, van dijk d, van paassen j. Cochrane Database Syst Rev. 2011 May 11;(5):CD005566. doi: 10.1002/14651858.CD005566.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2024 Mar 20;3:CD005566. doi: 10.1002/14651858.CD005566.pub4 PMID: 21563145 Updated. Review.
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Klok FA, et al. Among authors: van der meer njm, van paassen j. Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10. Thromb Res. 2020. PMID: 32291094 Free PMC article.
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Klok FA, et al. Among authors: van der meer njm, van paassen j. Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30. Thromb Res. 2020. PMID: 32381264 Free PMC article.
Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study.
Moes DJAR, van Westerloo DJ, Arend SM, Swen JJ, de Vries A, Guchelaar HJ, Joosten SA, de Boer MGJ, van Gelder T, van Paassen J. Moes DJAR, et al. Among authors: van paassen j. Clin Pharmacokinet. 2022 Feb;61(2):231-247. doi: 10.1007/s40262-021-01074-2. Epub 2021 Oct 11. Clin Pharmacokinet. 2022. PMID: 34633645 Free PMC article.
Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
van Grootveld R, van der Beek MT, Janssen NAF, Ergün M, van Dijk K, Bethlehem C, Stads S, van Paassen J, Heunks LMA, Bouman CSC, Reijers MHE, Brüggeman RJ, van de Veerdonk FL, van Bree SHW, van den Berg CHSB, Kuindersma M, Wauters J, Beishuizen A, Verweij PE, Schouten JA; CAPA2.0 study group. van Grootveld R, et al. Among authors: van paassen j. J Crit Care. 2023 Aug;76:154272. doi: 10.1016/j.jcrc.2023.154272. Epub 2023 Feb 16. J Crit Care. 2023. PMID: 36801598 Free PMC article.
33 results